HealthPlus Pharmacy Group — Appendices
Supporting detail and reference material underpinning the HealthPlus Pharmacy Group business plan.
Section 16 · Business Plan
Appendices
Supporting detail and reference material underpinning the HealthPlus Pharmacy Group business plan.
Appendix A: Detailed Monthly Cash Flow — Year 1
| Month | Revenue | COGS | OpEx | Net Cash | Cumulative |
|---|---|---|---|---|---|
| Month 1 | 0.0 | 0.0 | (0.8) | (0.8) | (0.8) |
| Month 2 | 0.0 | 0.0 | (0.8) | (0.8) | (1.6) |
| Month 3 | 0.0 | 0.0 | (0.9) | (0.9) | (2.5) |
| Month 4 | 0.0 | 0.0 | (0.9) | (0.9) | (3.4) |
| Month 5 | 0.0 | 0.0 | (1.0) | (1.0) | (4.4) |
| Month 6 | 0.5 | (0.3) | (1.2) | (1.0) | (5.4) |
| Month 7 | 1.8 | (1.2) | (1.5) | (0.9) | (6.3) |
| Month 8 | 3.5 | (2.3) | (1.8) | (0.6) | (6.9) |
| Month 9 | 5.2 | (3.4) | (2.0) | (0.2) | (7.1) |
| Month 10 | 6.8 | (4.5) | (2.2) | 0.1 | (7.0) |
| Month 11 | 8.5 | (5.6) | (2.5) | 0.4 | (6.6) |
| Month 12 | 10.2 | (6.7) | (2.8) | 0.7 | (5.9) |
Appendix B: Key Personnel Compensation Framework
| Level | Base Salary (R) | Short-Term Incentive | Long-Term Incentive | Total Package |
|---|---|---|---|---|
| C-Suite (CEO/CFO) | 1.2–1.8M | 30–50% of base | Share options (vesting 3yr) | R1.8–3.0M |
| COO/CTO | 1.0–1.5M | 25–40% of base | Share options (vesting 3yr) | R1.5–2.5M |
| Head of Pharmacy | 0.8–1.2M | 20–30% of base | Share options (vesting 3yr) | R1.1–1.8M |
| Store Manager | 0.48–0.6M | 15–25% of base | Profit share scheme | R0.6–0.8M |
| Pharmacist | 0.48–0.78M | 10–20% of base | Retention bonus | R0.55–0.95M |
Appendix C: Market Comparable Valuation Benchmarks
| Company | Revenue (R’B) | EBITDA Margin | P/E Ratio | EV/EBITDA | Stores |
|---|---|---|---|---|---|
| Clicks Group | 45.4 | ~11.5% | ~25x | ~16x | 990+ |
| Dis-Chem Pharmacies | 39.2 | ~8.5% | ~22x | ~14x | 260+ |
| Shoprite (Pharmacy Div.) | n/a | n/a | ~18x | ~10x | 400+ |
| HealthPlus (Year 5 Proj.) | 0.51 | 18.8% | n/a | 4.5–5.5x | 25 |
Appendix D: SWOT Analysis
| Category | Details |
|---|---|
| Strengths | Digital-first model with WhatsApp Rx ordering; modern store design; data-driven loyalty ecosystem; lean corporate structure; aggressive private label strategy |
| Weaknesses | No existing brand recognition; limited initial scale vs incumbents; dependence on external wholesalers in Phase 1; capital-intensive expansion model |
| Opportunities | Underserved catchments vacated by independent pharmacies; growing chronic disease burden; NHI implementation may expand funded patient pool; e-commerce penetration at early stages |
| Threats | Aggressive incumbent response (pricing, location pre-emption); pharmacist shortage; regulatory delays; macroeconomic deterioration reducing consumer spend; supply chain disruption |
Appendix E: Glossary of Terms
| Term | Definition |
|---|---|
| B-BBEE | Broad-Based Black Economic Empowerment—South Africa’s legislative framework for economic transformation |
| CAGR | Compound Annual Growth Rate |
| EBITDA | Earnings Before Interest, Tax, Depreciation, and Amortisation |
| EDLP | Everyday Low Pricing—a retail pricing strategy offering consistently low prices |
| GPP | Good Pharmacy Practice—standards prescribed by the SAPC for pharmacy operations |
| IRR | Internal Rate of Return |
| NHI | National Health Insurance—South Africa’s proposed universal healthcare coverage system |
| OTC | Over-the-Counter—medicines available without a prescription |
| SAHPRA | South African Health Products Regulatory Authority |
| SAPC | South African Pharmacy Council—the regulatory body for pharmacists and pharmacy premises |
| SEP | Single Exit Price—the regulated maximum price for medicines in South Africa |
| SKU | Stock Keeping Unit—a unique identifier for each product variant |
Appendix F: Key Data Sources and References
The market data, industry statistics, and competitive intelligence
presented in this business plan have been sourced from the following
primary and secondary sources:
- South African Pharmacy Council (SAPC) — Regulatory framework,
licensing requirements, registered pharmacy statistics - South African Health Products Regulatory Authority (SAHPRA) —
Medicine registration, scheduling, and regulatory compliance
requirements - Clicks Group Limited — Integrated Annual Report 2024, Interim
Results February 2025, Investor Presentations - Dis-Chem Pharmacies Limited — Audited Annual Consolidated Results
February 2025, Strategic Review Documents - Statista Market Forecasts — Pharmaceuticals and Pharmacies market
data for South Africa (2024–2029 projections) - BlueWeave Consulting — South Africa Retail Pharmacy Market Size,
Share and Demand Report 2030 - Grand View Research / Horizon Databook — South Africa
Pharmaceutical Market Outlook 2026–2033 - Credence Research — Africa Retail Pharmacy Market Size, Share and
Forecast 2032 - Coronation Fund Managers — Dis-Chem Investment Analysis: An
Attractive Company in a Resilient Sector (Q1 2025) - Department of Health, Republic of South Africa — Pharmacy
Premises Licensing Guidelines and Criteria - National Department of Health — National Health Insurance Act and
Implementation Framework - Heart and Stroke Foundation South Africa — Chronic disease
prevalence and mortality statistics - Statistics South Africa — Population demographics, GDP
contribution by province, Consumer Price Index data - DrugPatentWatch — South Africa Pharmaceutical Landscape Analysis
(February 2026) - IndexBox — South Africa Pharmaceutical Market Analysis, Forecast,
Size, Trends and Insights
All financial projections, assumptions, and strategic assessments
are the proprietary work product of HealthPlus Pharmacy Group (Pty) Ltd
management, informed by the above sources and supplemented by direct
industry consultation and management experience.
────────────────────────────────────────
END OF BUSINESS PLAN
HealthPlus Pharmacy Group (Pty) Ltd
For enquiries: investors@healthpluspharmacy.co.za
Confidential — this business plan is provided to prospective investors and lenders for evaluation purposes only and may not be reproduced or distributed without the written consent of HealthPlus Pharmacy Group (Pty) Ltd.